Arizona and Taiwan strengthen cooperation in biomedicine and digital health
Arizona officials and representatives from Taiwan’s healthcare sector signed a Declaration of Collaboration aimed at strengthening ties in research, biomedical innovation, and technological development. The agreement seeks to consolidate Arizona as a strategic hub for Taiwanese healthcare companies looking to expand their presence in the United States and other international markets.
The signing took place on October 9 at the Venture Café in Phoenix, with the participation of the Arizona Commerce Authority, Arizona State University (ASU), the City of Phoenix, and the Taiwan Digital Health Industry Development Association (TAIDHA).
As part of the event, the Taiwan AI Smart Health Exhibition Hall, located at the Phoenix Bioscience Center, was inaugurated. Representatives from 15 Taiwanese companies participated in the event, presenting medical technologies and innovations in biomedicine, artificial intelligence, and medical devices. The space will serve as a meeting point for the promotion of joint projects and connections between academic, clinical, and research institutions.
The purpose of the Collaboration Statement is to establish the AI Smart Health Exhibition Center, where companies can present their developments and seek partnerships in Arizona, as well as to promote joint research and clinical collaboration with U.S. institutions. It also aims to support the commercial expansion of Taiwanese companies through distribution and investment networks, offer regulatory guidance to facilitate their entry into the US market, and promote academic and professional exchange in health, technology, and biomedicine.
The document was signed by Sandra Watson, president of the Arizona Trade Authority; Sally Morton, executive vice president of ASU; Kate Gallego, mayor of Phoenix; and Jean Yang, president of Huijia Health, representing TAIDHA.
During the ceremony, officials highlighted that the alliance represents an opportunity to strengthen economic and scientific cooperation between the two regions. “The launch of this center promotes international collaboration and reinforces Phoenix’s role as a hub for innovation in biosciences,” said Mayor Gallego.
Arizona’s biomedical ecosystem has grown in recent years with the establishment of research centers and technology corridors linked to institutions such as the Mayo Clinic, ASU, and the Phoenix Biosciences Center, consolidating its role as one of the main hubs of development in the southwestern United States.
Among the companies participating in the exhibition are PHARMIGENE, Inno-Health Technology (Aculife), Brain Navi Biotechnology, Somnics Inc., Elite BioMedical, ProtectLife International Biomedical, and Huijia Health Life Technology, among others.
